MarketBeat shows that Zacks lowered EndoChoice Holdings stock from a "hold" rating to a "sell" rating, according to EMQ News & Analysis.
Here are four notes:
1. EndoChoice Holdings has a 12-month low of $6.23 and a 12-month high of $19.69.
2. The company has a 50-day moving average of $8.17 and a 200-day moving average of $12.29.
3. The firm's market cap is $163.65 million.
4. On average, EndoChoice Holdings has a rating of "buy" and a target price of $23.33.